Nigerian Billionaire Ty Danjuma's May Baker To Expand Manufacturing With New Facility

May Baker, majority-owned by billionaire TY Danjuma, to build a new pharmaceutical plant in Anambra, boosting local drug production and economic growth.

The company expands its herbal medicine portfolio with science-backed products for domestic and export markets, leveraging indigenous plants and local expertise.

H1 2025 revenue surges 38 to N19.28 billion, driven by strong pharmaceutical sales and innovation-focused product expansion.

May Baker Plc, one of Nigerias leading pharmaceutical companies, majority-owned by Nigerian billionaire Theophilus Yakubu TY Danjuma, is expanding its manufacturing footprint with a new facility in Anambra State, reinforcing its commitment to Nigerias local drug production and economic growth.

CEO Patrick Ajah revealed the plan during the 2025 Annual Conference of the Association of Community Pharmacists of Nigeria in Awka, Anambras capital. Speaking alongside Governor of Anambra State, Chukwuma Soludo at the companys exhibition stand, Ajah confirmed the new facility will complement May Bakers existing depot operations in Onitsha.

We are heavily invested in producing quality medications locally and developing products from Nigerian research, Ajah said, noting the companys legacy as Nigerias first pharmaceutical manufacturer. Governor Soludo praised the firms innovation drive, highlighting that most drugs on display were produced at the May Baker Pharmacentre in Ota, Ogun State.

Ajah also spotlighted the companys herbal medicine venture, which leverages indigenous plants and Nigerian scientific expertise. Products include Roveda, derived from bitter leaf and developed by Benson Idahosa Universitys Vice Chancellor Prof. Ernest Izevbigie, and Niclovix, from the Nigerian Institute for Pharmaceutical Research and Development.

These herbal products merge science, local resources, and traditional knowledge, Ajah said, adding that May Baker is commercializing them to meet growing domestic and export demand. Soludo engaged extensively on the herbal portfolio, promising state support for investments that add value to Anambras economy.